Tag
2 articles
This article explains GPT-Rosalind, OpenAI's new domain-specific AI model for drug discovery and life sciences research, and how it represents a shift toward AI systems that enhance scientific reasoning rather than just automate tasks.
OpenAI introduces GPT-Rosalind, a specialized AI model designed to accelerate drug discovery, genomics analysis, and protein reasoning in life sciences research.
